The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor

Nor Syafinaz Yaakob, Dan Thanh Nguyen, Betty Exintaris, Helen Ruth Irving

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Serotonin type 3 (5-hydroxytrptamine-3, 5-HT3) receptors are ligand-gated cation channels present in both central and peripheral nervous systems. In humans there are five different subunits (A, B, C, D and E) of 5-HT3 receptors which can form homomeric or heteromeric receptors that may account for discrepancies in patient responses to treatments. The present study commences characterisation of the profiles of human 5-HT3 receptors containing C and/or E subunits. Recombinant 5-HT3 receptors were expressed transiently in HEK293T cells and expression was checked via immunocytochemistry staining against each epitope-tagged subunits. Functional characterisation of different combinations of 5-HT3 receptor complexes was studied via patch clamp whole cell recordings. In this study, increased current was seen in cells containing A and C subunits but only subtle changes were seen in the electrical properties of cells expressing A, AE, or ACE subunits in response to the ligand, 5-HT. Both di- and tri-heteromeric 5-HT3 receptors were significantly inhibited by the antagonists, ondansetron and palonosetron. Notably, palonosetron exerted stronger and more rapid inhibition on the 5-HT3 receptor ACE tri-heteromer compared to homomeric and di-heteromeric counterparts. This study demonstrated that the C and E subunits when assembled as simple or complex heteromeric 5-HT3 receptors may alter efficacies of 5-HT and clinically used antagonists such as ondansetron and palonosetron, and this in turn may have implications for patient responses to therapies.

Original languageEnglish
Pages (from-to)1701-1709
Number of pages9
JournalBiomedicine and Pharmacotherapy
Volume97
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

Fingerprint

Ondansetron
Serotonin
Ligand-Gated Ion Channels
Peripheral Nervous System
Patch-Clamp Techniques
Cations
Epitopes
Central Nervous System
Immunohistochemistry
Staining and Labeling
Ligands
Therapeutics
palonosetron

Keywords

  • HTR3C
  • HTR3E
  • Ligand-gated ion channel
  • Ondansetron
  • Palonosetron
  • Patch-clamp

ASJC Scopus subject areas

  • Pharmacology

Cite this

The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor. / Yaakob, Nor Syafinaz; Nguyen, Dan Thanh; Exintaris, Betty; Irving, Helen Ruth.

In: Biomedicine and Pharmacotherapy, Vol. 97, 01.01.2018, p. 1701-1709.

Research output: Contribution to journalArticle

@article{3b1a4acb52494ba0a7bc750f4e026ad2,
title = "The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor",
abstract = "Serotonin type 3 (5-hydroxytrptamine-3, 5-HT3) receptors are ligand-gated cation channels present in both central and peripheral nervous systems. In humans there are five different subunits (A, B, C, D and E) of 5-HT3 receptors which can form homomeric or heteromeric receptors that may account for discrepancies in patient responses to treatments. The present study commences characterisation of the profiles of human 5-HT3 receptors containing C and/or E subunits. Recombinant 5-HT3 receptors were expressed transiently in HEK293T cells and expression was checked via immunocytochemistry staining against each epitope-tagged subunits. Functional characterisation of different combinations of 5-HT3 receptor complexes was studied via patch clamp whole cell recordings. In this study, increased current was seen in cells containing A and C subunits but only subtle changes were seen in the electrical properties of cells expressing A, AE, or ACE subunits in response to the ligand, 5-HT. Both di- and tri-heteromeric 5-HT3 receptors were significantly inhibited by the antagonists, ondansetron and palonosetron. Notably, palonosetron exerted stronger and more rapid inhibition on the 5-HT3 receptor ACE tri-heteromer compared to homomeric and di-heteromeric counterparts. This study demonstrated that the C and E subunits when assembled as simple or complex heteromeric 5-HT3 receptors may alter efficacies of 5-HT and clinically used antagonists such as ondansetron and palonosetron, and this in turn may have implications for patient responses to therapies.",
keywords = "HTR3C, HTR3E, Ligand-gated ion channel, Ondansetron, Palonosetron, Patch-clamp",
author = "Yaakob, {Nor Syafinaz} and Nguyen, {Dan Thanh} and Betty Exintaris and Irving, {Helen Ruth}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.biopha.2017.12.010",
language = "English",
volume = "97",
pages = "1701--1709",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor

AU - Yaakob, Nor Syafinaz

AU - Nguyen, Dan Thanh

AU - Exintaris, Betty

AU - Irving, Helen Ruth

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Serotonin type 3 (5-hydroxytrptamine-3, 5-HT3) receptors are ligand-gated cation channels present in both central and peripheral nervous systems. In humans there are five different subunits (A, B, C, D and E) of 5-HT3 receptors which can form homomeric or heteromeric receptors that may account for discrepancies in patient responses to treatments. The present study commences characterisation of the profiles of human 5-HT3 receptors containing C and/or E subunits. Recombinant 5-HT3 receptors were expressed transiently in HEK293T cells and expression was checked via immunocytochemistry staining against each epitope-tagged subunits. Functional characterisation of different combinations of 5-HT3 receptor complexes was studied via patch clamp whole cell recordings. In this study, increased current was seen in cells containing A and C subunits but only subtle changes were seen in the electrical properties of cells expressing A, AE, or ACE subunits in response to the ligand, 5-HT. Both di- and tri-heteromeric 5-HT3 receptors were significantly inhibited by the antagonists, ondansetron and palonosetron. Notably, palonosetron exerted stronger and more rapid inhibition on the 5-HT3 receptor ACE tri-heteromer compared to homomeric and di-heteromeric counterparts. This study demonstrated that the C and E subunits when assembled as simple or complex heteromeric 5-HT3 receptors may alter efficacies of 5-HT and clinically used antagonists such as ondansetron and palonosetron, and this in turn may have implications for patient responses to therapies.

AB - Serotonin type 3 (5-hydroxytrptamine-3, 5-HT3) receptors are ligand-gated cation channels present in both central and peripheral nervous systems. In humans there are five different subunits (A, B, C, D and E) of 5-HT3 receptors which can form homomeric or heteromeric receptors that may account for discrepancies in patient responses to treatments. The present study commences characterisation of the profiles of human 5-HT3 receptors containing C and/or E subunits. Recombinant 5-HT3 receptors were expressed transiently in HEK293T cells and expression was checked via immunocytochemistry staining against each epitope-tagged subunits. Functional characterisation of different combinations of 5-HT3 receptor complexes was studied via patch clamp whole cell recordings. In this study, increased current was seen in cells containing A and C subunits but only subtle changes were seen in the electrical properties of cells expressing A, AE, or ACE subunits in response to the ligand, 5-HT. Both di- and tri-heteromeric 5-HT3 receptors were significantly inhibited by the antagonists, ondansetron and palonosetron. Notably, palonosetron exerted stronger and more rapid inhibition on the 5-HT3 receptor ACE tri-heteromer compared to homomeric and di-heteromeric counterparts. This study demonstrated that the C and E subunits when assembled as simple or complex heteromeric 5-HT3 receptors may alter efficacies of 5-HT and clinically used antagonists such as ondansetron and palonosetron, and this in turn may have implications for patient responses to therapies.

KW - HTR3C

KW - HTR3E

KW - Ligand-gated ion channel

KW - Ondansetron

KW - Palonosetron

KW - Patch-clamp

UR - http://www.scopus.com/inward/record.url?scp=85037637650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037637650&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.12.010

DO - 10.1016/j.biopha.2017.12.010

M3 - Article

C2 - 29793334

AN - SCOPUS:85037637650

VL - 97

SP - 1701

EP - 1709

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -